What is Talkspace's gross profit margin?

Did Talkspace beat or miss consensus estimates last quarter?

What factors drove the changes in Talkspace's revenue and profit?

What does Talkspace do and what are its main business segments?

What were the key takeaways from Talkspace’s earnings call?

What is the market's earnings forecast for Talkspace next quarter?

What guidance did Talkspace's management provide for the next earnings period?

What were the key takeaways from Talkspace's earnings call?

- **Revenue Surge**: 22% YoY growth to $229 million, with Payor revenue up 38%. EBITDA doubles to $15.8 million.
- **AI Innovation**: TalkAI beta testing underway; general LLMs boost third-session completions by 49%.
- **2026 Outlook**: $275-290 million revenue (+20-27%), EBITDA $30-35 million (+90-122%). Payor growth and directory integrations key drivers.
- **Strategic Wins**: 45,000 teens in NYC Teenspace program show 66% improvement; Medicare expansion via CMS access program and Wisdo acquisition.

**【CEO Summary Section】**
- **Revenue Growth**: Full-year 2025 revenue of $229 million, up 22% YoY, driven by 38% Payor growth. Adjusted EBITDA doubled to $15.8 million (7% margin).
- **Payor Expansion**: Over 200 million lives covered through insurance partnerships. Q4 Payor revenue grew 41% YoY to $47.7 million, with 36.3% session volume increase.
- **AI Integration**: TalkAI beta testing aims to enhance patient journey with AI-driven mental health support, launching Q2 2026. General LLMs drove 49% increase in third-session completions.
- **Strategic Initiatives**: Military and Medicare enrollment growth, Wisdo acquisition for social health, and Teenspace program reaching 45,000 teens in NYC with 66% clinical improvement.

**【CFO Financial Commentary】**
- **Q4 2025 Results**: Revenue $63.0 million (+29.3% YoY), Payor revenue $47.7 million (+41% YoY). Adjusted EBITDA $6.6 million (+147% YoY), margin 10.4%.
- **2026 Guidance**: Revenue $275-290 million (+20-27% YoY), EBITDA $30-35 million (+90-122% YoY). Payor growth expected to continue, D2E low single-digit growth.
- **Balance Sheet**: $92.6 million cash, $17.2 million share buybacks in 2025.

**【Q&A Highlights】**
- **AI Strategy**: TalkAI beta testing shows high engagement; direct-to-consumer launch planned Q2 2026. General LLMs drive 49% increase in third-session completions.
- **Payor Integration**: 3 new directory integrations in 2026, reducing friction for Payor members. 30-50% of 2026 Payor revenue from existing members.
- **Medicare Expansion**: CMS access program participation; Wisdo acquisition boosts Medicare Advantage interest. Value-based contracts with Payors.
- **Network Growth**: Psychiatrist network expanded to 400 providers; Amazon Pharmacy integration for prescription convenience.

Talkspace, Inc. (TALK) Q4 2025 Earnings Call Transcript

- **Revenue Acceleration**: Q3 payer revenue surged 42% YoY to $45.5M, with 29% member growth and 37% session growth.
- **AI Breakthrough**: Proprietary mental health LLM outperforms general AI with 50% better risk detection and 47% higher user satisfaction.
- **Wisdo Integration**: Peer-to-peer coaching launch with Novo Nordisk targets weight management adherence.
- **2026 Outlook**: 20%+ revenue growth and $14-16M EBITDA, with AI products set to launch mid-2026.
- **Operational Efficiency**: 11% sequential expense decline and 8.4% EBITDA margin reflect strong cost control.


**CEO Summary Section**
- Q3 revenue reached $59.4 million, up 25% year-over-year, driven by 42% growth in payer revenue to $45.5 million.
- Active payer members increased 29% YoY to 120,000, with sessions up 37% YoY.
- AI initiatives boosted third session bookings by 30% and completions by 31%.
- Acquired Wisdo Health for peer-to-peer coaching, launching with Novo Nordisk's Wegovy app.
- Developed proprietary mental health LLM with 50% better risk detection than general AI models.

**CFO Financial Commentary**
- Adjusted EBITDA rose to $5 million (8.4% margin), up from $2.3 million in Q2.
- Total operating expenses decreased 11% sequentially to $22.4 million.
- Full-year 2025 guidance narrowed to $226-230 million revenue and $14-16 million EBITDA.
- 2026 outlook includes 20%+ revenue growth and expanding EBITDA margins.

**Q&A Highlights**
- **AI Monetization**: CEO Cohen revealed plans to launch AI products in H1 2026, targeting consumers, employers, and payers with HIPAA-compliant clinical oversight.
- **Medicare Strategy**: Q3 Medicare growth lagged commercial payer momentum, but Wisdo integration aims to address loneliness and adherence in seniors.
- **Network Capacity**: CFO Harris confirmed network sufficiency, with dynamic scheduling and 12% sequential growth in smart insights adoption.
- **Marketing Efficiency**: S&M spend up 4% YoY with 30%+ ROI, driving 8% sequential payer member growth.
- **Guidance Tightening**: EBITDA range reduced due to delayed Q3 launches, but 2026 growth prioritized over near-term profitability.


Talkspace, Inc. (TALK) Q3 2025 Earnings Call Transcript

- **Payer Growth Accelerates**: 35% YoY payer revenue growth ($40.5M) driven by 25% YoY active member increase
- **AI-Driven Engagement**: Taalcast boosts session completion by 14-29%, AI risk detection 92% accurate
- **Expansion Milestones**: 16M new insured lives, Medicare in all 50 states, $2.3M EBITDA (+93% YoY)
- **Pipeline Strength**: DTE pipeline up, with Q3 launches of $7M+ deals
- **Financial Health**: $103M cash, 18% total revenue growth, 43% gross margin
- **AI Innovation**: Behavioral LLMs trained on 12 years of clinical data, launching late 2025

**【CEO Summary Section】**
- Unique active payer members grew 10% sequentially (10,000 new members) and 25% YoY, the largest quarterly increase in 2 years.
- Payer sessions increased 10% sequentially and 29% YoY, driven by AI-driven engagement tools like Taalcast (podcasts that boost session completion rates by 14-29%).
- Expanded insurance coverage to 16 million new lives via Blues plans in Texas, Illinois, and Idaho, and added Medicare Advantage plans in all 50 states.
- Launched partnerships with Amazon Pharmacy (seamless prescription delivery) and Tia Health (integrated mental health care for women).
- AI innovations include: 
  - Smart evaluation tool saving therapists 10-15 minutes per session
  - 92% accurate suicide risk detection algorithm (up from 83%)
  - Behavioral health LLMs trained on 12 years of clinical data, expected to launch late 2025
- Direct-to-enterprise pipeline strengthened with wins like injuriRx and North Carolina youth mental health program

**【CFO Financial Commentary】**
- Total revenue: $54.3M (+18% YoY), payer revenue: $40.5M (+35% YoY)
- Gross margin: 43.1% (down 2.6pts YoY due to W-2 therapist hiring for scale)
- Operating expenses: $25.2M (+2.4% YoY), with CAC improving sequentially and YoY
- Adjusted EBITDA: $2.3M (+93% YoY)
- Cash balance: $103M (down $5.6M QoQ due to AI CapEx)
- Stock buybacks: $8.4M YTD
- Full-year guidance: Revenue $220-235M, EBITDA $14-20M

**【Q&A Key Highlights】**
- Medicare registrations growing month-over-month, with focus on clinical quality and safety
- AI model development prioritizes clinical oversight and HIPAA compliance
- DTE expected to grow low single-digits YoY in 2H25, driven by delayed Q2 deals launching in Q3
- Payer revenue growth >30% YoY in 2H25, fueled by 10,000 new Q2 users with long retention tails
- CAC improving sequentially and YoY due to product optimizations
- No material impact from state AI regulations; focus on clinical safety and privacy


Talkspace, Inc. (TALK) Q2 2025 Earnings Call Transcript

- **Revenue & Growth**: 15% YoY revenue growth, 23% session volume increase, 153% EBITDA rise, driven by Payor expansion and AI tools.
- **Clinical Success**: Medicare members show 84% improvement, exceeding 70% industry benchmark. Bark partnership reaches 7 million teens.
- **Financial Strength**: $108M cash, $300K net income, and $2M EBITDA. Full-year guidance targets 21% revenue growth.
- **Strategic Moves**: Developing AI-driven mental health model, expanding into TRICARE, and renewing enterprise contracts.
- **Market Resilience**: Insulated from Medicaid cuts, with 200M covered lives reducing out-of-pocket dependency.

**【CEO Summary Section】**
- **Revenue Growth**: Q1 2025 revenue of $52.2 million, up 15% YoY, driven by a 33% increase in Payor business. Session volume rose 23%, and EBITDA surged 153% YoY.
- **AI Innovations**: Launched Talkcast, generating 6,000 personalized podcasts, and validated a 90% accurate risk assessment tool for homicidal ideation. Developing a large language model for clinical applications.
- **Partnerships**: Expanded with Bark Technologies to integrate mental health support into 7 million children’s devices. Medicare campaign featuring Gary Livingston saw 84% clinical improvement in members.
- **Market Expansion**: Covered 200 million lives, including TRICARE West, and renewed contracts with Memphis, U.S. Navy, and University of Alaska.
- **Operational Efficiency**: Reduced funnel drop-off by 12% via real-time benefits verification and seamless EAP-to-insurance transitions.

**【CFO Financial Commentary】**
- **Financial Performance**: GAAP net income of $300,000 (vs. $1.5M loss YoY), Adjusted EBITDA of $2.0 million (+144% YoY). Gross margin 44.6%, down from 47.8% YoY due to Payor mix shift.
- **Balance Sheet**: $108 million cash, with $7 million share buybacks in Q1, total $18 million since program launch.
- **Guidance**: Full-year revenue $220-235 million (+21% midpoint), EBITDA $14-20 million (+144% midpoint).

**【Q&A Highlights】**
- **Medicare Expansion**: 84% clinical improvement in Medicare members, targeting MA plans for value-based contracts. Marketing spend flexible, prioritizing ROI.
- **Technology Impact**: Easy button for EAP-to-insurance transitions reduced drop-off, with 17% YoY growth in Payor members.
- **Sales & Marketing**: Q2 marketing spend similar to Q1, focusing on military and Medicare. Bark partnership leverages AI for teen mental health.
- **Risk Management**: Insulated from Medicaid changes, with 200 million covered lives reducing reliance on out-of-pocket spending.

Talkspace (TALK)-6 May 25-2025 Q1 Earnings call transcript

- **Revenue Surge**: 25% YoY growth to $187.6M, driven by Payor expansion (179M lives) and 45% session volume increase.
- **Profitability Milestone**: Full-year EBITDA turned positive ($7M vs -$13.5M), with $1.2M GAAP net income.
- **AI-Driven Innovation**: Talkcast enhances member engagement, leveraging 10B+ clinical data points for personalized care.
- **2025 Outlook**: Target $220-235M revenue (+21% midpoint), fueled by Medicare, military, and commercial Payor growth.
- **Operational Excellence**: 11% G&A expense reduction, reinvested in high-ROI marketing and tech enhancements.


**【CEO Key Highlights】**
- **2024 Revenue Growth**: 25% YoY to $187.6M, with session volume up 45% and EBITDA improving by $20.5M (from -$13.5M to +$7M). Payor business now covers 179M lives, including Medicare, military, and teens.
- **Strategic Shift**: Transitioned from consumer subscription to Payor-focused model, reducing operating expenses by $7M while maintaining high-quality clinical network of 6,000 providers.
- **AI Innovation**: Introduced Talkcast, a personalized podcast tool for providers, leveraging 10B+ clinical data points to enhance member engagement and outcomes.
- **Market Expansion**: Launched in Medicare (48 states), TRICARE West (9.5M military), and Seattle (55K teens). 57% of teen users are in high-disparity areas.

**【CFO Financial Breakdown】**
- **Q4 2024 Results**: Revenue $48.7M (+15% YoY), Payor revenue +33%, Payor sessions +32% to 330K. Gross margin 44.2% (down 5.2pts YoY due to Payor mix shift).
- **Profitability**: Full-year GAAP net income $1.2M (vs -$20.3M in 2023), cash reserves $118M with no debt.
- **2025 Outlook**: Revenue $220-235M (+21% midpoint), EBITDA $14-20M. Focus on Medicare, military, and commercial Payor growth, with selective marketing and tech investments.

**【Q&A Key Takeaways】**
- **Cost Efficiency**: G&A expenses down 11% YoY, with savings reinvested in high-ROI marketing (e.g., Medicare, military outreach) and AI-driven member engagement tools.
- **Payor Pricing**: Stable rates with major contracts renewed, no signs of margin compression.
- **Marketing Strategy**: Diversifying channels for Medicare (direct mail, in-person events) and leveraging partnerships (e.g., Amazon, ZocDoc) for cost-effective acquisition.
- **Growth Drivers**: Payor sessions growth (+32% Q4) and DTE expansion (Seattle, Navy) will fuel top-line expansion, offsetting consumer decline.


Actual	-0.125	0.01	-0.14	-0.13	-0.15	-0.11	-0.11	-0.05	-0.03	-0.03	-0.01	-0.01	0	0.01	0.01	0	0	0.02	0.03
Forecast	-0.03	-0.0947	-0.1336	-0.1433	-0.1241	-0.1164	-0.1119	-0.07	-0.0506	-0.03	-0.0294	-0.0071	-0.002	0.0013	0.0066	0	0.0053	0.0181	0.0208
Surprise	-316.67%	+110.56%	-4.79%	+9.28%	-20.87%	+5.50%	+1.70%	+28.57%	+40.71%	0.00%	+65.99%	-40.85%	+100.00%	+669.23%	+51.52%	0.00%	-100.00%	+10.50%	+44.23%

TALK

TALK fundamentals

TALK Q4 2025 Earnings

Earnings Call

You can ask Aime

TALK

TALK fundamentals

TALK Q4 2025 Earnings

Earnings Call

TALK Earnings Call Summary for Q4/20258:30 AM on Feb 19, 2026

TALK Earnings Call Summary for Q3/20258:30 AM on Oct 30, 2025

TALK Earnings Call Summary for Q2/20258:30 AM on Aug 5, 2025

TALK Earnings Call Summary for Q1/20258:30 AM on May 6, 2025

TALK Earnings Call Summary for Q4/20248:30 AM on Feb 20, 2025

You can ask Aime